AbbVie Inc.
NYSE-ABBV
Basic
Market Cap
$287.98B
EV
$335.78B
Shares Out
1,770.65M
Revenue
$54.4B
Employees
50,000
Margins
Gross
69.17%
EBITDA
49.4%
Operating
33.33%
Pre-Tax
13.84%
Net
11.02%
FCF
40.62%
Returns (5Yr Avg)
ROA
6.74%
ROTA
-16.62%
ROE
60.96%
ROCE
19.77%
ROIC
18.27%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$182.65
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$12.82B
Net Debt
$47.76B
Debt/Equity
5.83
EBIT/Interest
8.16
Growth (CAGR)
Rev 3Yr
2.72%
Rev 5Yr
10.75%
Rev 10Yr
11.08%
Dil EPS 3Yr
4.87%
Dil EPS 5Yr
-0.87%
Dil EPS 10Yr
2.72%
Rev Fwd 2Yr
3.11%
EBITDA Fwd 2Yr
5.24%
EPS Fwd 2Yr
4.41%
EPS LT Growth Est
8.27%
Dividends
Yield
—
Payout
179.99%
DPS
$6.06
DPS Growth 3Yr
6.9%
DPS Growth 5Yr
8.34%
DPS Growth 10Yr
14.1%
DPS Growth Fwd 2Yr
4.32%
Select a metric from the list below to chart it
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM
Dec '24 (E)
Dec '25 (E)
Dec '26 (E)